HealthCor Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-321,200
Closed -$29.3M 90
2020
Q4
$29.3M Buy
321,200
+97,340
+43% +$8.07M 1.13% 28
2020
Q3
$17.9M Buy
+223,860
New +$17.5M 0.72% 28
2020
Q1
Sell
-399,630
Closed -$31.1M 51
2019
Q4
$31.1M Sell
399,630
-1,478,340
-79% -$115M 1.11% 37
2019
Q3
$138M Buy
1,877,970
+11,280
+0.6% +$792K 5.2% 1
2019
Q2
$115M Buy
+1,866,690
New +$113M 4.46% 3
2018
Q4
Sell
-1,361,145
Closed -$79M 44
2018
Q3
$79M Buy
+1,361,145
New +$66.6M 2.62% 18
2017
Q4
Sell
-1,015,470
Closed -$37M 38
2017
Q3
$37M Sell
1,015,470
-2,584,530
-72% -$98.6M 1.24% 27
2017
Q2
$142M Sell
3,600,000
-150,000
-4% -$5.48M 5.12% 4
2017
Q1
$118M Buy
+3,750,000
New +$117M 5.39% 5
2016
Q4
Sell
-2,700,000
Closed -$109M 46
2016
Q3
$109M Sell
2,700,000
-1,800,000
-40% -$67.8M 6.61% 4
2016
Q2
$150M Buy
4,500,000
+2,025,000
+82% +$69.3M 8.16% 1
2016
Q1
$72.8M Buy
2,475,000
+2,187,720
+762% +$60.4M 4.12% 10
2015
Q4
$7.56M Sell
287,280
-4,362,720
-94% -$113M 0.46% 33
2015
Q3
$110M Sell
4,650,000
-1,950,000
-30% -$47.1M 6.2% 2
2015
Q2
$157M Buy
6,600,000
+5,100,000
+340% +$115M 7.89% 1
2015
Q1
$35.6M Buy
+1,500,000
New +$33.7M 1.7% 25
2013
Q4
Sell
-3,000,000
Closed -$34.8M 59
2013
Q3
$34.8M Buy
+3,000,000
New +$35.1M 1.87% 23

Other funds holding EW

HealthCor Management's EW Position: Q1 2021 in Review

HealthCor Management sold out of Edwards Lifesciences (EW) in Q1 2021, closing a stake of 321,200 shares — an estimated $29.3M sold.

HealthCor Management first reported a position in EW in Q3 2013 and held it in 17 quarters. The position peaked at $157M in Q2 2015. 1,143 funds tracked by Wall St. Rank hold EW as of Q1 2021.

  • HealthCor Management reported no remaining Edwards Lifesciences position as of Q1 2021 after selling out during the quarter.
  • HealthCor Management sold 321,200 Edwards Lifesciences shares in Q1 2021, an estimated $29.3M.
  • HealthCor Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 17 quarters.
  • HealthCor Management's Edwards Lifesciences position peaked at $157M in Q2 2015.
  • 1,143 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2021.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.